Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Essex Property Trust, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Essex Property Trust, Inc. trades at $293.55 (market cap $18.86B). The key difference: Essex Property Trust, Inc. pays a 3.53% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | ESS | |
|---|---|---|
Sector | Sector/Thematic | Real Estate |
52-Week High | $43.57 | $298.33 |
52-Week Low | $23.09 | $239.61 |
Market Cap | — | $18.86B |
Enterprise Value | — | $25.59B |
Dividend Yield | — | 3.53% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ESS trades at $293.55, up 0.83% on the day, with a bullish technical signal and strong fundamental performance. The stock exhibits robust profitability with a 30.03% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights include the upcoming Q2 2026 earnings release and the company's addition to the Russell Microcap Index, reflecting positive momentum.
The outlook for ESS is supported by strong West Coast rental demand and AI-driven employment growth, though risks include high debt levels and Seattle market weakness. Analyst consensus is mixed with a $292.89 price target, slightly below the current price, indicating cautious optimism amid valuation concerns.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →